In addition to effects via induction of the VDR, S179D PRL has additional anti-prostate cancer benefit derived from interruption of the autocrine PRL growth loop mediated through PRLRLF signaling [5, 9]. The gene discussed is PRL; the disease is prostate carcinoma.